LPCN - Lipocine Inc logo

LPCN

Lipocine Inc

Rev โ€”top 1%10Y
Hold

Lipocine Inc. develops pharmaceutical products targeting neurological and psychiatric disorders, liver disease, and hormone replacement. Its key offerings include TLANDO, an oral testosterone therapy, and candidates for postpartum depression and epilepsy management.

โš•๏ธ Healthcare NASDAQ Listed 2013 $ USD
$1,000 invested 10 years ago โ†’$27today

Score Overview

1 Year
Score
Net Growth-23.10%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-20.60%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score1.4
Net Growth-16x
Net Trend20%
Net Income Consistencyโ€”
Rev Growth-90.28%
Rev Trend20%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth37.53%
Net Trend30%
Net Income Consistency
Rev Growthโ€”
Rev Trend30%
Revenue Consistency
All Time
Scoreโ€”
Net Growth-11.91%
Net Trend31%
Net Income Consistency
Rev Growthโ€”
Rev Trend23%
Revenue Consistency

See the full market ranking โ†’

Lipocine Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 0.00 to $ 1M and net income went from -$ 20M to -$ 9M. Revenue increased in 1 of those 5 years; net income in 1.

Lipocine Inc currently holds a 5-year HDB Score of 1.4 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 2.06โ€”
1 Year2025-08-12
$ 2.97-30.64%
5 Years2021-08-12
$ 25.33-91.87%
10 Years2016-08-12
$ 76.16-97.30%
All Time2013-10-22
$ 170.00-98.79%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 1M-$ 11M$ 23M
2025$ 1M-$ 9M$ 14M
2024$ 11M$ 8.35K$ 21M
2023-$ 2M-$ 16M$ 22M
2022$ 500K-$ 10M$ 32M
2021$ 16M-$ 634.4K$ 44M
2020$ 0.00-$ 20M$ 19M
2019$ 164.99K-$ 13M$ 14M
2018$ 428.03K-$ 11M$ 15M
2017$ 0.00-$ 20M$ 21M
2016$ 0.00-$ 18M$ 26M
2015$ 0.00-$ 18M$ 44M
2014$ 0.00-$ 20M$ 27M
IPO2013$ 0.00-$ 10M$ 45M

Explore beyond LPCN

You're looking at Lipocine Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies